|
Volumn 154, Issue 4, 1997, Pages 588-590
|
Breast cancer risk in psychiatric patients [15] (multiple letters)
a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHLORPROMAZINE;
HALOPERIDOL;
NEUROLEPTIC AGENT;
PSYCHOTROPIC AGENT;
RESERPINE;
BREAST CANCER;
BREAST EXAMINATION;
CANCER INCIDENCE;
CANCER RISK;
CANCER SCREENING;
DISEASE ASSOCIATION;
DRUG CARCINOGENICITY;
FEMALE;
HIGH RISK PATIENT;
HUMAN;
LETTER;
MAMMOGRAPHY;
MENTAL PATIENT;
PREVALENCE;
PRIORITY JOURNAL;
PSYCHIATRIC DIAGNOSIS;
RISK BENEFIT ANALYSIS;
SCHIZOPHRENIA;
BREAST TUMOR;
COHORT ANALYSIS;
COMORBIDITY;
EPIDEMIOLOGY;
MENTAL DISEASE;
NOTE;
RISK FACTOR;
INCIDENCE;
METHODOLOGY;
STANDARD;
BIAS (EPIDEMIOLOGY);
BREAST NEOPLASMS;
COHORT STUDIES;
COMORBIDITY;
FEMALE;
HUMANS;
MENTAL DISORDERS;
PREVALENCE;
RISK FACTORS;
INCIDENCE;
RESEARCH DESIGN;
|
EID: 0030901792
PISSN: 0002953X
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (4)
|
References (0)
|